Enovis CORP Quarterly Goodwill in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Enovis CORP quarterly Goodwill history and growth rate from Q4 2010 to Q2 2024.
  • Enovis CORP Goodwill for the quarter ending June 28, 2024 was $2.35B, a 15.7% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.35B +$319M +15.7% Jun 28, 2024 10-Q 2024-08-07
Q1 2024 $2.41B +$427M +21.5% Mar 29, 2024 10-Q 2024-05-02
Q4 2023 $2.06B +$77.3M +3.9% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $2.03B +$67.4M +3.44% Sep 29, 2023 10-Q 2023-11-07
Q2 2023 $2.03B +$109M +5.66% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.99B -$1.45B -42.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.98B +$49.3M +2.55% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.96B -$1.54B -44% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $1.93B -$1.47B -43.4% Jul 1, 2022 10-Q 2022-08-04
Q1 2022 $3.44B +$109M +3.27% Apr 1, 2022 10-Q 2022-05-10
Q4 2021 $1.93B +$173M +9.82% Dec 31, 2021 10-K 2024-02-22
Q3 2021 $3.5B +$252M +7.78% Oct 1, 2021 10-Q 2021-11-04
Q2 2021 $3.4B +$189M +5.89% Jul 2, 2021 10-Q 2021-07-28
Q1 2021 $3.33B +$140M +4.39% Apr 2, 2021 10-Q 2021-04-29
Q4 2020 $1.76B -$1.44B -45% Dec 31, 2020 10-K 2023-03-01
Q3 2020 $3.25B +$461M +16.6% Oct 2, 2020 10-Q 2020-10-29
Q2 2020 $3.21B +$388M +13.7% Jul 3, 2020 10-Q 2020-08-06
Q1 2020 $3.19B -$661M -17.2% Apr 3, 2020 10-Q 2020-05-07
Q4 2019 $3.2B +$1.7B +114% Dec 31, 2019 10-K 2022-02-22
Q3 2019 $2.78B +$260M +10.3% Sep 27, 2019 10-Q 2019-10-31
Q2 2019 $2.82B +$317M +12.6% Jun 28, 2019 10-Q 2019-08-06
Q1 2019 $3.85B +$1.24B +47.5% Mar 29, 2019 10-Q 2019-05-08
Q4 2018 $1.5B +$67.5M +4.72% Dec 31, 2018 10-K 2021-02-18
Q3 2018 $2.52B -$3.01M -0.12% Sep 28, 2018 10-Q 2018-10-25
Q2 2018 $2.51B -$181M -6.75% Jun 29, 2018 10-Q 2018-08-06
Q1 2018 $2.61B +$24M +0.93% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $1.43B -$921M -39.2% Dec 31, 2017 10-K 2020-02-24
Q3 2017 $2.53B -$105M -4% Sep 29, 2017 10-Q 2017-11-06
Q2 2017 $2.69B +$20.7M +0.78% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $2.59B -$181M -6.55% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $2.35B -$247M -9.51% Dec 31, 2016 10-K 2019-02-21
Q3 2016 $2.63B -$244M -8.47% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $2.67B -$194M -6.79% Jul 1, 2016 10-Q 2016-07-28
Q1 2016 $2.77B +$5.35M +0.19% Apr 1, 2016 10-Q 2016-05-03
Q4 2015 $2.6B -$275M -9.57% Dec 31, 2015 10-K 2018-02-16
Q3 2015 $2.88B -$71.3M -2.42% Sep 25, 2015 10-Q 2015-10-22
Q2 2015 $2.86B -$206M -6.71% Jun 26, 2015 10-Q 2015-07-23
Q1 2015 $2.76B +$374M +15.6% Mar 27, 2015 10-Q 2015-04-23
Q4 2014 $2.87B +$463M +19.2% Dec 31, 2014 10-K 2017-02-14
Q3 2014 $2.95B +$866M +41.6% Sep 26, 2014 10-Q 2014-10-23
Q2 2014 $3.07B +$1.09B +55.2% Jun 27, 2014 10-Q 2014-07-25
Q1 2014 $2.39B +$411M +20.8% Mar 28, 2014 10-Q 2014-04-24
Q4 2013 $2.41B +$311M +14.8% Dec 31, 2013 10-K 2016-02-16
Q3 2013 $2.08B +$152M +7.89% Sep 27, 2013 10-Q 2013-10-24
Q2 2013 $1.98B +$122M +6.6% Jun 28, 2013 10-Q 2013-07-25
Q1 2013 $1.98B +$109M +5.81% Mar 29, 2013 10-Q 2013-04-25
Q4 2012 $2.1B +$1.89B +925% Dec 31, 2012 10-K 2015-02-17
Q3 2012 $1.93B +$1.75B +948% Sep 28, 2012 10-Q 2012-10-31
Q2 2012 $1.85B +$1.66B +880% Jun 29, 2012 10-Q 2012-08-07
Q1 2012 $1.87B Mar 30, 2012 10-Q 2012-05-08
Q4 2011 $205M +$32.5M +18.9% Dec 31, 2011 10-K 2014-02-12
Q3 2011 $184M Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $189M Jul 1, 2011 10-Q 2011-07-29
Q4 2010 $172M Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.